logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
L

Louis P. Garrison

University of Washington

48H指数
331论文数
9.5K被引数
收录论文 155
发表时间
logo
Extent and causes of the collapse in the registration of innovative medications in Lebanon: A mixed-methods analysis黎巴嫩创新药物注册崩溃的广度与原因：一项混合方法分析
errPLoS One
IF2.6
err2025-12-26
err0
PREAI
errMina, Wadih; Nahas, Hanadi; Lteif, Maria Rita; Karam, Rita; El-Jardali, Fadi; Garrison, Louis; Nasser, Soumana C.
err分享
err收藏
A novel framework to assess the prevention value of a health intervention一种评估健康干预预防价值的新型框架
errDiabetes, Obesity and Metabolism
IF0
err2025-11-05
err0
errOAAI
errJonathan Pearson-Stuttard FRSPH; Catrin Treharne MSc; Robert King MSc; Hugo Harper MSc; Irina Pokhilenko PhD; Manuel Gomes PhD; Louis Garrison PhD; Ricardo Reynoso MD; Jutta Kloppenborg Heick Skau PhD; Katherine Byrne MA
err分享
err收藏
Metrics that matter: Identifying endpoints for capturing the broad health impacts of prevention of obesity关键指标：识别用于捕捉肥胖预防广泛健康影响的终点指标
errdiabetes obesity metabolism
IF0
err2025-08-25
err0
errOAAI
errJonathan Pearson-Stuttard FRSPH; Sara Holloway FdSc; Jamie Kettle MMath; Hugo Harper MSc; Irina Pokhilenko PhD; Manuel Gomes PhD; Louis Garrison PhD; Ricardo Reynoso MD; Katherine Byrne MA; Jutta Kloppenborg Heick Skau PhD
err分享
err收藏
Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States美国复发或难治性多发性骨髓瘤患者中，teclistamab和elranatamab的每应答者成本
errJournal of Medical Economics
IF3
err2025-06-14
err0
errOAAI
errLucio N. Gordan; Arielle G. Bensimon; Fan Mu; Nina Kim; Bingcao Wu; Dee Lin; Agne Paner; Jessica Fowler; Alex Marshall; Suzy Van Sanden; Eric Ammann; Joe Goble; Xinke Zhang; Hoa H. Le; Elissa E. Min; Louis P. Garrison Jr.
err分享
err收藏
A prospective model of the potential clinical and economic impact of cervical cancer screening supported by a mobile phone app一种基于手机应用程序的宫颈癌筛查潜在临床和经济影响的展望模型
errPLOS ONE
IF2.6
err2025-01-31
err0
errOAAI
errAsirwa, Fredrick Chite; Bresnahan, Brian W.; Yego, Faith; Duncan, Dana; Karichu, James K.; Garrison Jr., Louis P.
err分享
err收藏
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases
errADVANCES IN THERAPY
IF4
err2024-12-20
err1
errOAAI
errYang, Min; Mittal, Manish; Fendrick, A. Mark; Brixner, Diana; Sherman, Bruce W.; Liu, Yifei; Patel, Pankaj; Clewell, Jerry; Liu, Qing; Garrison Jr, Louis P.
err分享
err收藏
Does Real Option Value Influence Oncologists' Treatment Recommendations? A Survey of US Oncologists
errVALUE IN HEALTH
IF6
err2024-12-01
err0
PREAI
errLi, Meng; Elsisi, Zizi; Wong, William; Kowal, Stacey; Veenstra, David L.; Garrison Jr, Louis P.
err分享
err收藏
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases健康经济学与结果研究中价值概念的发展：用于罕见病细胞与基因治疗创新及可及性的新兴工具
errVALUE IN HEALTH
IF6
err2024-12-01
err1
PREAI
errToro, Walter; Yang, Min; Patel, Anish; Zhang, Su; Dabbous, Omar; Garrison Jr, Louis P.
err分享
err收藏
Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer's Disease in the United States估计在美国使用Donanemab进行有限时间治疗以治疗早期症状性阿尔茨海默氏病的经济合理价格
errNEUROLOGY AND THERAPY
IF4.8
err2024-09-18
err0
errOAAI
errBoustani, Malaz; Doty, Erin G.; Garrison Jr, Louis P.; Smolen, Lee J.; Klein, Timothy M.; Murphy, Daniel R.; Spargo, Andrew W.; Belger, Mark; Johnston, Joseph A.
err分享
err收藏
Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019
errVALUE IN HEALTH
IF6
err2024-08-01
err2
errOAAI
errGarrison Jr, Louis P.; Jiao, Boshen; Elsisi, Zizi; Yehoshua, Alon; Koruth, Roy; Kreter, Bruce; Grueger, Jens
err分享
err收藏
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations for Expanding Valuation by Including Key Concepts在卫生技术评估和卫生经济学中捕获疫苗接种的价值-通过包括关键概念来扩展评估的实际考虑
errVACCINES
IF3.4
err2024-07-15
err2
errOAAI
errBiundo, Eliana; Dronova, Mariia; Chicoye, Annie; Cookson, Richard; Devlin, Nancy; Doherty, T. Mark; Garcia, Stephanie; Garcia-Ruiz, Antonio J.; Garrison, Louis P.; Nolan, Terry; Postma, Maarten; Salisbury, David; Shah, Hiral; Sheikh, Shazia; Smith, Richard; Toumi, Mondher; Wasem, Jurgen; Beck, Ekkehard
err分享
err收藏
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study一次性疗法的循证价值评估: Tisagenlecleucel案例研究
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2024-04-29
err0
errOAAI
errLaetsch, Theodore; Zhang, Jie; Yang, Hongbo; Xie, Yanwen; Zhang, Dudan; Garrison, Louis
err分享
err收藏
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework评估扩大与限制一线治疗选择的政策: 成本效益分析框架
errVALUE IN HEALTH
IF6
err2024-04-01
err3
PREAI
errJiao, Boshen; Carlson, Josh J.; Garrison, Louis P., Jr.; Basu, Anirban
err分享
err收藏
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health Benefits
errPATIENT-PATIENT CENTERED OUTCOMES RESEARCH
IF3.1
err2024-02-29
err0
PREAI
errMarsh, Kevin; Collacott, Hannah; Thomson, Jim; Mauer, Jonathan; Watt, Stephen; Shah, Koonal; Hauber, Brett; Garrison, Louis; Dzingina, Mendwas
err分享
err收藏
New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement
errVACCINES
IF3.4
err2024-02-24
err0
errOAAI
errBuck, Philip O.; Gomes, Dumingu Aparna; Beck, Ekkehard; Kirson, Noam; Mattera, Matthew; Carroll, Stuart; Ultsch, Bernhard; Jayasundara, Kavisha; Uhart, Mathieu; Garrison, Louis P.
err分享
err收藏
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2024-02-05
err2
errOAAI
errShinkins, Bethany; Allen, A. Joy; Karichu, James; Garrison, Louis P.; Monz, Brigitta U.
err分享
err收藏
Is the price right? Paying for value today to get more value tomorrow
errBMC MEDICINE
IF8.3
err2024-01-30
err2
errOAAI
errRamagopalan, Sreeram V.; Diaz, Jose; Mitchell, Grace; Garrison, Louis P.; Kolchinsky, Peter
err分享
err收藏
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations
errFUTURE ONCOLOGY
IF2.6
err2024-01-23
err1
errOAAI
errWong, William; Kowal, Stacey; To, Tu My; Patel, Achal; Veenstra, David; Garrison, Louis; Li, Meng
err分享
err收藏
Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next?
errVALUE IN HEALTH
IF6
err2024-01-01
err0
PREAI
errGarrison Jr, Louis P.
err分享
err收藏
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient
errTRANSPLANTATION AND CELLULAR THERAPY
IF4.4
err2023-10-01
err4
errOAAI
errMaziarz, Richard T.; Devine, Steven; Garrison, Louis P.; Agodoa, Irene; Badaracco, Jack; Gitlin, Matthew; Perales, Miguel-Angel
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jasvinder A. Singh
H 指数: 145 · 论文数: 1.1K
D
Dennis C. Turk
H 指数: 125 · 论文数: 846
P
Philip J. Mease
H 指数: 117 · 论文数: 1.1K
R
Robert L. Goldenberg
H 指数: 116 · 论文数: 920
M
Mark P. Jensen
H 指数: 116 · 论文数: 952
查看更多